# A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer

> **NCT05208268** · — · COMPLETED · sponsor: **Eisai Korea Inc.** · enrollment: 676 (actual)

## Conditions studied

- Stomach Ulcer
- Duodenal Ulcer

## Interventions

- **DRUG:** Pariet

## Key facts

- **NCT ID:** NCT05208268
- **Lead sponsor:** Eisai Korea Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-23
- **Primary completion:** 2022-09-22
- **Final completion:** 2022-09-22
- **Target enrollment:** 676 (ACTUAL)
- **Last updated:** 2022-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05208268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05208268, "A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05208268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*